Pivotal Study of the Velocity™ pAVF System

Launched by VENOVA MEDICAL ·

Keywords

ClinConnect Summary

This clinical trial is studying a new way to create a special blood vessel connection called an arteriovenous fistula (AVF), which is used for dialysis in people with kidney failure. Usually, creating an AVF requires surgery, which can mean cuts, longer healing time, and sometimes extra procedures before it can be used. This study will test the Velocity™ pAVF System, a less invasive method that makes this connection through a small puncture in the skin, using a thin tube called a catheter. The goal is to see if this new method is safe and works well for patients who need dialysis.

Adults with kidney failure who need an AVF for dialysis may be eligible to join the study. Participants will have the Velocity procedure and then be monitored closely with check-ups, ultrasounds, and dialysis tests for up to five years to see how well the fistula works and how safe the procedure is. Taking part is voluntary, and while some patients might benefit from a quicker recovery and less invasive procedure, the main purpose is to gather information that could help improve care for future patients with kidney failure.

Gender

ALL

Eligibility criteria